Search clinical trials for: Glucagon for Injection (Fresenius Kabi USA)

Total 74 results

Fresenius Kabi USA, LLC

Completed

Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories)

Hypoglycemia

United States
Göteborg University

Terminated

Saline Injections for Prophylactic Treatment of Chronic Migraine

Chronic Migraine

Sweden
Wei Zhou

Unknown

Parenteral Fish Oil in Major Laparoscopic Abdominal Surgery

Liver Tumor | Gastric Tumor | Pancreatic Tumor

China
Ulrik Grevstad

Completed

Effect of Adductor Canal Block vs. Placebo on Muscle Strength, Mobilisation and Pain After Total Knee Arthroplasty

Knee Replacement Arthroplasty

Denmark
Xeris Pharmaceuticals

Completed

Glucagon Ready-to-Use (RTU) for Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults With T1D

Hypoglycemia

Canada
KAI Pharmaceuticals

Completed

Safety of KAI-9803 for Injection With Angioplasty Following Heart Attack

Myocardial Infarction

United States
Daniel Stephan Engeler

Completed

Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors

Neoplasm of Lateral Wall of Urinary Bladder

Switzerland
Bio-Thera Solutions

Not yet recruiting

A Study to Evaluate PK, Efficacy, and Safety of BAT3306 Plus Chemo and Compare With Keytruda®(EU/US) in Participants With IV nqNSCLC

Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company
Locemia Solutions ULC

Completed

Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia (AMG102)

Hypoglycemia

Canada
Indiana University

Completed

Determining the Sensitivity of Sentinel Lymph Nodes Identified With Robotic Fluorescence Imaging (FIRES)

Cervical Cancer | Endometrial Cancer

United States
Medical University of Vienna

Completed

Evaluation of Two Methods of Jejunal Placement of Enteral Feeding Tubes in Critically Ill Patients

Critically Ill

Austria
OPKO Health, Inc.

Completed

Effects of TT301 on Cytokine Levels Post Endotoxin Challenge

Traumatic Brain Injury

United States
Daren K. Heyland
Fresenius Kabi

Completed

Trial of Glutamine and Antioxidant Supplementation in Critically Ill Patients (REDOXS)

Sepsis | Critical Illness | Multiple Organ Failure

United States, Canada, Belgium, Switzerland, Germany
DynPort Vaccine Company LLC, A GDIT Company

Withdrawn

Phase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/B (rBV A/B)

Botulism
Shanghai University of Traditional Chinese Medicine

Unknown

Relationship Between the Activity of Rheumatoid Arthritis and Lymph Node Morphology and Lymphatics Drainage

Rheumatoid Arthritis | Lymph Node Mass | Lymphatic Vessel; Dilatation

China
B. Braun Medical Inc.

Completed

Pharmacokinetics and Safety of Cefazolin 3gm DUPLEX in Adults (3gCefPK)

Infections

United States
Nanjing University

Recruiting

Umbilical Cord Artery-derived Perivascular Stem Cells for the Critical Limb Ischemia Therapy

Critical Limb Ischemia

China
University of Pennsylvania

Completed

Intraoperative Imaging of Thoracic Malignancies With Indocyanine Green

Lung Neoplasms

United States
Outi Aikio

Completed

Extremely Low Gestatonal Age Infants' Paracetamol Study (Paras)

Prematurity; Extreme | Low Birthweight, Extremely (999 Grams or Less)

Finland
Zealand Pharma
Massachusetts General Hospital; Beta Bionics, Inc.

Completed

Feasibility Trial Testing the Bionic Pancreas With ZP4207 (dasiglucagon)

Diabetes Mellitus, Type 1

United States
B. Braun Medical Inc.
Parexel

Completed

Pharmacokinetics and Safety of Cefazolin 2g in DUPLEX (2 Cef)

Infection

United States
Theraclone Sciences, Inc.

Completed

Safety Study of Human Anti-Cytomegalovirus Monoclonal Antibody

Cytomegalovirus Infections

United States
NovaBay Pharmaceuticals, Inc.

Completed

Study to Evaluate NVC-422 for Urinary Catheter Blockage and Encrustation

Urinary Catheter Blockage and Encrustation

United States
Eicos Sciences, Inc.

Completed

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)

Raynaud Phenomenon Secondary to Systemic Sclerosis

United States
Peter Vestergaard
Aalborg University

Completed

Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet. (DENOCINA)

Primary Hyperparathyroidism | Parathyroid Adenoma | Parathyroid Hyperplasia

Denmark
Merck Sharp & Dohme LLC

Completed

A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insulin (MK-0893-002)

Type 2 Diabetes Mellitus
Eicos Sciences, Inc.

Completed

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3)

Raynaud's Phenomenon Secondary to Systemic Sclerosis

United States
University of Virginia
Novo Nordisk A/S

Unknown

Study of Glucagon, Ghrelin and Growth Hormone as Counterregulatory Hormones

Healthy

United States
Brigham and Women's Hospital

Completed

Replication of the SEPRA Diabetes Trial in Healthcare Claims Data

Diabetes Mellitus, Type 2

United States
University of Florida

Terminated

Clinical Trials to Reduce the Risk of Antimicrobial Resistance

Bacterial Pneumonia

United States, Spain, France, Germany
Ospedale Policlinico San Martino
Bayer; Associazione Italiana per la Ricerca sul Cancro; Gruppo Italiano per lo...

Recruiting

Adjuvant Durvalumab Plus Regorafenib vs Untreated Control in Stage IV Colorectal Cancer Patients With no Evidence of Disease (NED): VIVA Trial (VIVA)

Colorectal Cancer Stage IV | No Evidence of Disease State

Italy
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Drug Levels of an Antibody Against HIV in Healthy, HIV-Uninfected Adults

HIV Infections

United States
Children's Hospital of Philadelphia
The Ray E. Helfer Society

Active, not recruiting

Effectiveness of Contrast-Enhanced Ultrasound

Abdominal Injuries | Accidental Fall | Physical Abuse | Motor Vehicle Injury

United States
Universidad del Desarrollo

Completed

Is Anesthetic Loss of Consciousness a Top Down or Bottom up Phenomenon. What Does the Neurologic Examination Say?. (Top&Bottom)

Anesthesia; Functional

Chile
HIV Prevention Trials Network
National Institute on Drug Abuse (NIDA); National Institute of Allergy and...

Enrolling by invitation

INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit (INTEGRA)

HIV Infections | Opioid Use | Drug Use | Opioid-use Disorder

United States
University of Oulu
Turku University Hospital; Helsinki University Central Hospital; Tampere University...

Recruiting

Paracetamol And Ibuprofen/Indomethacin in Closing Patent Ductus Arteriosus (PAI)

Patent Ductus Arteriosus

Finland
Glenn-Milo Santos
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Active, not recruiting

Addressing Heavy Alcohol Use Consumption With Kudzu (A-HACK)

Sexually Transmitted Diseases | Alcohol Use Disorder

United States
DynPort Vaccine Company LLC, A GDIT Company

Completed

Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B

Botulism Vaccine

United States
scPharmaceuticals, Inc.

Completed

Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure

Heart Failure

United States
Hospital for Special Surgery, New York
The Hospital for Sick Children; Boston Children's Hospital

Recruiting

A Randomized Controlled Trial of Leg Length Discrepancy Techniques

Leg Length Discrepancy

United States, Canada
Vaxart
Biomedical Advanced Research and Development Authority

Completed

A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine

Influenza

United States
ImmunityBio, Inc.

Terminated

QUILT-3.063: A Study of N-803, haNK and Avelumab in Patients With Merkel Cell Carcinoma That Has Progressed After Checkpoint Therapy

Merkel Cell Carcinoma

United States
SQ Innovation, Inc.
Accel Clinical Services

Completed

Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure

Heart Failure

United States
David Hess, MD
National Institute of Neurological Disorders and Stroke (NINDS); Oregon Health... and other collaborators

Completed

Study of a Neuroprotective Drug to Limit the Extent of Damage From an Ischemic Stroke (MINOS)

Stroke, Acute

United States
Southeast Retina Center, Georgia

Unknown

Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH (LASERLESS)

Proliferative Diabetic Retinopathy

United States
Peking University Cancer Hospital & Institute

Not yet recruiting

Study of Oncolytic Virus in Combination With HX-008 and Radiotherapy in Melanoma Patients With Liver Metastasis

Melanoma Stage IV
Bio-Thera Solutions

Not yet recruiting

BAT1308 Combined With Platinum-Based Chemotherapy± Bevacizumab For PDL1-Positive (CPS ≥1) Cervical Cancer

Cervical Cancer

China
INSYS Therapeutics Inc

Completed

Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer

Neoplasm

United States, Germany, Netherlands
Felix Gutierrez
Hospital Clinic of Barcelona; Hospital General Universitario Elche; Germans Trias... and other collaborators

Recruiting

IMPACt of an Enhanced Screening Program on the Detection of Non-AIDS NEOplasms in HIV Patients (IMPACNEO)

Cancer | HIV/AIDS

Spain
Grifols Therapeutics LLC

Active, not recruiting

Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD) (SPARTA)

Pulmonary Emphysema in Alpha-1 PI Deficiency

United States, Australia, Denmark, New Zealand, Estonia, Poland, Russian Federation, Sweden, Brazil, Canada, France, Finland

Search clinical trials for: Glucagon for Injection (Fresenius Kabi USA)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations